Master Immunohematology: Advanced Transfusion Medicine MCQs – 10 MCQs | Kenya MBChB
10 Year 3: Blood Transfusion exam questions on Master Immunohematology: Advanced Transfusion Medicine MCQs for medical students. Includes MCQs, answers, explana
This MCQ set contains 10 questions on Master Immunohematology: Advanced Transfusion Medicine MCQs in the Year 3: Blood Transfusion unit. Each question includes the correct answer and a detailed explanation for active recall and exam preparation.
Q1: A patient with a known anti-Jk(a) antibody requires an urgent transfusion. The current antibody screen is negative. What is the most appropriate next step to ensure a safe transfusion?
- A. Provide Jk(a) negative units even if the crossmatch is compatible.
- B. Provide crossmatch-compatible units regardless of Jk(a) status.
- C. Perform an elution on the patient's pre-transfusion sample.
- D. Administer intravenous immunoglobulin (IVIG) prior to transfusion.
Correct answer: A – Provide Jk(a) negative units even if the crossmatch is compatible.
Kidd antibodies can become undetectable over time, but the patient remains sensitized. A historic antibody must always be respected — always provide antigen-negative units regardless of current screen results.
Q2: In a patient with warm autoimmune hemolytic anemia (WAIHA) and a pan-reactive antibody screen, which method is used to detect underlying alloantibodies if the patient has been transfused in the last 3 months?
- A. Autologous adsorption
- B. Allogeneic adsorption using phenotype-matched cells
- C. Acid elution
- D. Saline replacement technique
Correct answer: B – Allogeneic adsorption using phenotype-matched cells
Autologous adsorption can't be used in recently transfused patients (donor cells would adsorb the alloantibody too). Allogeneic adsorption with phenotype-matched cells removes the autoantibody while preserving detectable alloantibodies.
Q3: Which blood group system is most frequently associated with delayed hemolytic transfusion reactions that present with a rapid drop in hemoglobin but negative initial antibody screens?
- A. Kell
- B. Duffy
- C. Kidd
- D. MNS
Correct answer: C – Kidd
The Kidd system is the classic cause of delayed hemolytic transfusion reactions. Antibodies fade quickly, screen negative, then surge after re-exposure causing rapid intravascular hemolysis.
Q4: A 32-year-old female experiences severe hypotension and bronchospasm within minutes of starting a red cell transfusion. She has a history of recurrent respiratory infections. What is the most likely underlying deficiency?
- A. Haptoglobin deficiency
- B. Selective IgA deficiency
- C. C1 esterase inhibitor deficiency
- D. Albumin deficiency
Correct answer: B – Selective IgA deficiency
IgA-deficient patients can develop anti-IgA antibodies. Transfusion of blood products containing IgA triggers a severe anaphylactic reaction. Recurrent infections are a clue to the underlying immunodeficiency.
Q5: Which specific modification to blood products is required to prevent Transfusion-Associated Graft-versus-Host Disease (TA-GvHD) in an immunocompromised bone marrow transplant recipient?
- A. Leukoreduction
- B. Washing with saline
- C. Irradiation
- D. Volume reduction
Correct answer: C – Irradiation
Irradiation inactivates donor T-lymphocytes, which are responsible for TA-GvHD. Leukoreduction reduces but does not eliminate T-cells — only gamma or X-ray irradiation reliably prevents TA-GvHD.
Q6: During a massive transfusion protocol, a patient develops ionized hypocalcemia. This is most likely a direct metabolic consequence of which preservative/anticoagulant used in blood storage?
- A. Heparin
- B. Sodium Citrate
- C. Adenine
- D. Dextrose
Correct answer: B – Sodium Citrate
Sodium citrate is used as an anticoagulant in blood storage. It chelates (binds) free ionized calcium, causing hypocalcemia during massive transfusion when large volumes are infused rapidly.
Q7: A neonate requires an exchange transfusion for HDFN caused by anti-c. The mother is O positive, R1R1 (CDe/CDe). The infant is A positive, R1r (CDe/ce). What is the most appropriate blood type for the exchange?
- A. O positive, c-negative (R1R1) RBCs
- B. A positive, c-negative (R1R1) RBCs
- C. O positive, c-positive (rr) RBCs
- D. AB positive, c-negative (R1R1) RBCs
Correct answer: A – O positive, c-negative (R1R1) RBCs
Blood must be c-negative to avoid destruction by maternal anti-c still circulating in the neonate. O type is chosen over A to be compatible with any residual maternal ABO antibodies. c-negative (R1R1) is essential.
Q8: TRALI is most commonly caused by antibodies in the donor plasma directed against which of the following in the recipient?
- A. Red cell antigens
- B. Platelet glycoproteins
- C. HLA or Human Neutrophil Antigens (HNA)
- D. Plasma proteins like albumin
Correct answer: C – HLA or Human Neutrophil Antigens (HNA)
Donor anti-HLA or anti-HNA antibodies bind to recipient neutrophils, activating them in the pulmonary vasculature and causing the capillary leak that defines TRALI (acute lung injury within 6 hours of transfusion).
Q9: What is the shelf life of a unit of Red Blood Cells that has been 'opened' by entering the system for washing or aliquoting in an open system, if stored at 1-6°C?
- A. 4 hours
- B. 24 hours
- C. 7 days
- D. 42 days
Correct answer: B – 24 hours
Once the sterile seal of a blood unit is broken (open system), the risk of bacterial contamination requires discarding the unit within 24 hours when stored at 1–6°C.
Q10: A patient is found to have the 'Bombay' phenotype (Oh). Which of the following statements regarding their transfusion needs is correct?
- A. They can safely receive Type O negative blood.
- B. They can receive any Rh-negative blood.
- C. They can only receive blood from another Bombay phenotype donor.
- D. They require H-substance neutralized plasma.
Correct answer: C – They can only receive blood from another Bombay phenotype donor.
Bombay phenotype patients lack H antigen entirely and have anti-H, anti-A, and anti-B antibodies. They will hemolyze all standard blood including O negative. Only another Bombay phenotype donor is compatible.
View on OmpathStudy